Back to Agendas
Session 3 : Risk-based Monitoring
Session Chair(s)
Yumi Sugiura, MRCP
Global Clinical Operations, Global Data Management and Centralized Monitoring
Bristol-Myers Squibb K.K., Japan
Mariko Mizumoto
Associate Director, Electronic Data System Mgt Gr, Clinical Data & Biostats Dept
Daiichi Sankyo Co., Ltd., Japan
Speaker(s)
Risk-based Monitoring - Lilly Experience
Misato Kuwagaki, MS
Eli Lilly Japan K.K., Japan
Associate Director, Data Sciences
Risk-based Monitoring – Novartis Experience
Junichi Nikaido
Novartis Pharma K.K., Japan
Field Operation 5, Japan International Clinical Research Operation Dept
Case Study: Addressing Key Aspects of the EMA Refl ection Paper on Risk-based Quality Monitoring - Quality Tolerance Limits and Quality Report
William Andrew Lawton
Risk Based Approach Ltd, United Kingdom
Director / Consultant
Expectationsfor medical institutions ?the systemrequiredin medical institution?
Kaori Watanabe, MPharm
The University of Tokyo Hospital, Japan
CRC, Clinical Research Promotion Center
Have an account?